287 related articles for article (PubMed ID: 9519488)
1. Patterns of symptom complaints in methadone maintenance patients.
Dyer KR; White JM
Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488
[TBL] [Abstract][Full Text] [Related]
2. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
Elkader AK; Brands B; Dunn E; Selby P; Sproule BA
J Clin Psychopharmacol; 2009 Feb; 29(1):77-81. PubMed ID: 19142113
[TBL] [Abstract][Full Text] [Related]
3. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
4. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
[TBL] [Abstract][Full Text] [Related]
5. Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment.
Elkader AK; Brands B; Callaghan R; Sproule BA
Drug Alcohol Depend; 2009 Dec; 105(3):209-14. PubMed ID: 19713051
[TBL] [Abstract][Full Text] [Related]
6. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence.
Mitchell TB; White JM; Somogyi AA; Bochner F
Addiction; 2004 Aug; 99(8):940-5. PubMed ID: 15265090
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy.
Eder H; Jagsch R; Kraigher D; Primorac A; Ebner N; Fischer G
Addiction; 2005 Aug; 100(8):1101-9. PubMed ID: 16042640
[TBL] [Abstract][Full Text] [Related]
8. The effects of racemic D,L-methadone and L-methadone in substituted patients--a randomized controlled study.
Verthein U; Ullmann R; Lachmann A; Düring A; Koch B; Meyer-Thompson HG; Schmidt R; Reimer J; Haasen C
Drug Alcohol Depend; 2005 Nov; 80(2):267-71. PubMed ID: 15916866
[TBL] [Abstract][Full Text] [Related]
9. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of mental and physical health disorders among older methadone patients.
Rosen D; Smith ML; Reynolds CF
Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
[TBL] [Abstract][Full Text] [Related]
11. Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients.
Mitchell TB; Dyer KR; Newcombe D; Somogyi AA; White JM
Addict Biol; 2006 Jun; 11(2):170-4. PubMed ID: 16800831
[TBL] [Abstract][Full Text] [Related]
12. Symptom complaints of patients prescribed either oral methadone or injectable heroin.
Dürsteler-MacFarland KM; Fischer DA; Mueller S; Schmid O; Moldovanyi A; Wiesbeck GA
J Subst Abuse Treat; 2010 Jun; 38(4):328-37. PubMed ID: 20206457
[TBL] [Abstract][Full Text] [Related]
13. Methadone maintenance treatment: the need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment.
Trujols J; Siñol N; de los Cobos JP
J Clin Psychopharmacol; 2010 Feb; 30(1):95-6; author reply 96. PubMed ID: 20075667
[No Abstract] [Full Text] [Related]
14. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
15. Excessive alcohol consumption is associated with reduced quality of life among methadone patients.
Senbanjo R; Wolff K; Marshall J
Addiction; 2007 Feb; 102(2):257-63. PubMed ID: 17222280
[TBL] [Abstract][Full Text] [Related]
16. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
[TBL] [Abstract][Full Text] [Related]
17. Methadone medical maintenance in primary care. An implementation evaluation.
Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
[TBL] [Abstract][Full Text] [Related]
18. Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment.
Tuchman E
Soc Work Health Care; 2007; 45(4):43-62. PubMed ID: 17954448
[TBL] [Abstract][Full Text] [Related]
19. Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
Hermann D; Klages E; Welzel H; Mann K; Croissant B
Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669
[TBL] [Abstract][Full Text] [Related]
20. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
